NEW YORK STATE COMMON RETIREMENT FUND - AXSOME THERAPEUTICS INC ownership

AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 184 filers reported holding AXSOME THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.99 and the average weighting 0.4%.

Quarter-by-quarter ownership
NEW YORK STATE COMMON RETIREMENT FUND ownership history of AXSOME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,747
+3.1%
24,995
+6.0%
0.00%
+50.0%
Q2 2023$1,694
+8.2%
23,570
-7.1%
0.00%0.0%
Q1 2023$1,565
-33.3%
25,366
-16.7%
0.00%
-33.3%
Q4 2022$2,348
-99.8%
30,439
+41.1%
0.00%
+200.0%
Q3 2022$963,000
+17.0%
21,573
+0.4%
0.00%0.0%
Q2 2022$823,000
-7.6%
21,495
-0.2%
0.00%0.0%
Q1 2022$891,000
+9.5%
21,5380.0%0.00%0.0%
Q4 2021$814,000
-91.6%
21,538
-92.6%
0.00%
-90.0%
Q3 2021$9,643,000
-52.0%
292,555
-1.7%
0.01%
-52.4%
Q2 2021$20,076,000
+16.8%
297,594
-2.0%
0.02%
+10.5%
Q1 2021$17,191,000
-16.9%
303,622
+19.5%
0.02%
-17.4%
Q4 2020$20,696,000
+40.4%
254,034
+22.8%
0.02%
+27.8%
Q3 2020$14,745,000
+34.7%
206,952
+55.6%
0.02%
+28.6%
Q2 2020$10,946,000
+50.3%
133,031
+7.5%
0.01%
+27.3%
Q1 2020$7,283,000
+2.2%
123,793
+79.5%
0.01%
+37.5%
Q4 2019$7,126,000
+1130.7%
68,948
+141.1%
0.01%
+700.0%
Q3 2019$579,000
-10.1%
28,600
+14.4%
0.00%0.0%
Q2 2019$644,000
+1851.5%
25,000
+198.6%
0.00%
Q1 2017$33,000
-42.1%
8,372
+0.0%
0.00%
Q4 2016$57,000
-13.6%
8,3710.0%0.00%
Q3 2016$66,000
+4.8%
8,3710.0%0.00%
Q2 2016$63,0008,3710.00%
Other shareholders
AXSOME THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
ALETHEA CAPITAL MANAGEMENT, LLC 1,132,645$37,332,00032.86%
MORGAN JESS S & CO INC 113,430$3,739,0002.47%
Fairmount Funds Management LLC 187,598$6,183,0002.25%
IRIDIAN ASSET MANAGEMENT LLC/CT 1,423,653$46,924,0001.43%
WMS Partners, LLC 250,000$8,240,0001.21%
Beck Bode, LLC 102,127$3,366,0000.94%
RTW INVESTMENTS, LP 1,616,497$53,280,0000.80%
MPM BioImpact LLC 110,155$3,631,0000.56%
Endurant Capital Management LP 52,048$1,716,0000.39%
Bellevue Group AG 752,945$24,817,0000.25%
View complete list of AXSOME THERAPEUTICS INC shareholders